Mercalis in Motion

Dissecting the CMS Best Price Rule: What it Means for Manufacturer Co-Pay Programs

July 01, 2021 TrialCard
Mercalis in Motion
Dissecting the CMS Best Price Rule: What it Means for Manufacturer Co-Pay Programs
Show Notes

In this podcast, Jason Zemcik, Sr. Director of Product Management at TrialCard, breaks down the implications of this rule, outlines strategies for manufacturers to address it, and provides insight on other drug pricing policy matters that could affect how manufacturers deliver patient support programs going forward.
.